The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| REPRO MED SYS INC | COM | 759910102 | 32,373 | 10,790,895 | SH | SOLE | 10,790,895 | 0 | 0 | ||
| WIRELESS TELECOM GROUP INC | COM | 976524108 | 3,332 | 1,514,509 | SH | SOLE | 1,514,509 | 0 | 0 | ||
| CYNERGISTEK INC | COM | 23258P105 | 1,140 | 791,819 | SH | SOLE | 791,819 | 0 | 0 | ||
| UROGEN PHARMA LTD | COM | M96088105 | 6,702 | 704,749 | SH | SOLE | 704,749 | 0 | 0 | ||
| SAFEGUARD SCIENTIFICS INC | COM NEW | 786449207 | 1,304 | 177,386 | SH | SOLE | 177,386 | 0 | 0 | ||